OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research Roundup

Debbie Rigby 31/03/2020

Debbie Rigby rounds up the latest in research news SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Based on currently available data and in view of the overwhelming evidence of mortality reduction in cardiovascular disease, ACE-I and ARB therapy should be maintained or initiated in patients with heart failure, hypertension,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Research Roundup

Previous Regulatory agility needed: Michaels

Next Banned from practice until Nov 2021

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Regulatory agility needed: Michaels

Next Banned from practice until Nov 2021

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.